AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,180,973 | +153.6% | 1,035,941 | +104.0% | 0.00% | – |
| Q2 2023 | $465,672 | +47.7% | 507,932 | -9.7% | 0.00% | – |
| Q1 2023 | $315,212 | -10.6% | 562,614 | -7.9% | 0.00% | – |
| Q4 2022 | $352,542 | +83.6% | 610,558 | +0.5% | 0.00% | – |
| Q3 2022 | $192,000 | -24.1% | 607,500 | -15.5% | 0.00% | – |
| Q2 2022 | $253,000 | -69.6% | 719,250 | -37.8% | 0.00% | – |
| Q1 2022 | $831,000 | -82.7% | 1,155,684 | -45.5% | 0.00% | – |
| Q4 2021 | $4,796,000 | +32.9% | 2,121,550 | +69.3% | 0.00% | – |
| Q3 2021 | $3,610,000 | -42.0% | 1,253,313 | -23.7% | 0.00% | -100.0% |
| Q2 2021 | $6,226,000 | -3.6% | 1,642,828 | -13.9% | 0.00% | 0.0% |
| Q1 2021 | $6,457,000 | -13.7% | 1,907,855 | -28.6% | 0.00% | – |
| Q4 2020 | $7,484,000 | +80.6% | 2,672,662 | +61.8% | 0.00% | – |
| Q3 2020 | $4,145,000 | -58.1% | 1,651,570 | +127.0% | 0.00% | -100.0% |
| Q2 2020 | $9,881,000 | +199.9% | 727,612 | +67.4% | 0.00% | – |
| Q1 2020 | $3,295,000 | +38.1% | 434,611 | +15.1% | 0.00% | – |
| Q4 2019 | $2,386,000 | +112.8% | 377,595 | +32.1% | 0.00% | – |
| Q3 2019 | $1,121,000 | -76.8% | 285,915 | -71.3% | 0.00% | – |
| Q2 2019 | $4,824,000 | +68.9% | 996,526 | +185.8% | 0.00% | -100.0% |
| Q1 2019 | $2,856,000 | -6.6% | 348,700 | -37.0% | 0.00% | 0.0% |
| Q4 2018 | $3,059,000 | +207.1% | 553,126 | +390.7% | 0.00% | – |
| Q3 2018 | $996,000 | -15.7% | 112,729 | -4.7% | 0.00% | – |
| Q2 2018 | $1,182,000 | +1106.1% | 118,312 | +1048.7% | 0.00% | – |
| Q1 2018 | $98,000 | -74.9% | 10,300 | -48.2% | 0.00% | – |
| Q3 2017 | $391,000 | -81.8% | 19,900 | -86.7% | 0.00% | – |
| Q2 2017 | $2,145,000 | +209.1% | 149,301 | +98.0% | 0.00% | – |
| Q1 2017 | $694,000 | -63.9% | 75,400 | -59.2% | 0.00% | – |
| Q4 2016 | $1,924,000 | -39.3% | 184,821 | -47.2% | 0.00% | -100.0% |
| Q3 2016 | $3,168,000 | +11.4% | 350,001 | -8.0% | 0.00% | +100.0% |
| Q2 2016 | $2,844,000 | +64.6% | 380,255 | +98.3% | 0.00% | – |
| Q1 2016 | $1,728,000 | -13.3% | 191,752 | +24.3% | 0.00% | -100.0% |
| Q4 2015 | $1,992,000 | +11.4% | 154,204 | -16.7% | 0.00% | – |
| Q3 2015 | $1,788,000 | +11.9% | 185,100 | +19.2% | 0.00% | – |
| Q2 2015 | $1,598,000 | +99.8% | 155,300 | +115.8% | 0.00% | – |
| Q1 2015 | $800,000 | +55.6% | 71,959 | +62.9% | 0.00% | – |
| Q4 2014 | $514,000 | -71.7% | 44,184 | -46.1% | 0.00% | -100.0% |
| Q3 2014 | $1,815,000 | +341.6% | 82,000 | +454.9% | 0.00% | – |
| Q2 2014 | $411,000 | – | 14,777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |